Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms

Oncogene

Volumn 25, Issue 1, 2006, Pages 61-69

  Anderson, C J ^a   Hoare, S F ^a   Ashcroft, M ^b   Bilsland, A E ^a   Keith, W N ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Chromatin; hTERT; hTR; Hypoxia; RNA splicing; Telomerase

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; PROTEIN P300; RNA POLYMERASE II; TELOMERASE; TRANSCRIPTION FACTOR IIB;

ARTICLE; CHROMATIN; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA SPLICING; TRANSCRIPTION INITIATION;

ALTERNATIVE SPLICING; ANOXIA; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; EXONS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUCIFERASES; P300-CBP TRANSCRIPTION FACTORS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RNA; RNA POLYMERASE II; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION; TELOMERASE; TELOMERE; TIME FACTORS; TRANSCRIPTION FACTOR TFIIB; TRANSCRIPTION, GENETIC; TRANSFECTION; VARIATION (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 30044436210     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1016/S1043-321X(06)80357-7     Document Type: Article

References (34)

1. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA et al. (1996). Proc Natl Acad Sci USA 93: 12969-12973.
2. Ashcroft M, Bardos JI. (2004). Bioessays 26: 262-269.
3. Atkinson SP, Hoare SF, Glasspool RM, Keith WN. (2005). Canc Res (in press).
4. Bilsland AE, Anderson CJ, Fletcher-Monaghan AJ, McGregor F, Evans TRJ, Ganly I et al. (2003). Oncogene 22: 370-380.
5. Blasco MA, Hahn WC. (2003). Trends Cell Biol 13: 289-294.
6. Chen H, Hahn S. (2004). Cell 119: 169-180.
7. Elsby LM, Roberts SGE. (2004). Biochem Soc Trans 32: 1098-1099.
8. Forsythe JA, Jiang B, Iyer NV, Agani F, Leung SW, Koos RD et al. (1996). Mol Cell Biol 16: 4604-4613.
9. Freedman SJ, Sun ZJ, Poy F, Kung AL, Livingston DM, Wagner G et al. (2002). Proc Natl Acad Sci USA 99: 5367-5372.
10. Gomez-Roman N, Grandori C, Eisenman RN, White RJ. (2003). Nature 421: 290-294.
11. Gorbunova V, Seluanov A, Pereira-Smith OM. (2002). J Biol Chem 277: 38540-38549.
12. Graven KK, Troxler RF, Kornfeld H, Panchenko MV, Farber HW. (1994). J Biol Chem 269: 24446-24453.
13. Hahn S. (2004). Nat Struct Mol Biol 11: 394-403.
14. Hashimoto Y, Zhang C, Kawauchi J, Imoto I, Adachi MT, Inazawa J et al. (2002). Nucleic Acid Res 30: 2398-2406.
15. Hockel M, Vaupel P. (2001). J Natl Cancer Inst 93: 266-276.
16. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H et al. (1998). EMBO J 17: 6573-6586.
17. Kilian A, Bowtell DDL, Abud HE, Hime GR, Venter DJ, Keese PK et al. (1997). Hum Mol Genet 6: 2011-2019.
18. Kornblihtt AR, De La Mata M, Fededa JP, Munoz MJ, Nogues G. (2004). RNA 10: 1489-1498.
19. Kung AL, Wang S, Klco JM, Kaelin Jr WG, Livingston DM. (2000). Nat Med 6: 1335-1340.
20. Luiten RM, Pene J, Yssel H, Spits H. (2003). Blood 101: 4512-4519.
21. Minamino T, Mitsialis SA, Kourembanas S. (2001). Mol Cell Biol 21: 3336-3342.
22. Misteli TaSDL. (1999). Mol Cell 3: 697-705.
23. Munch C, Zhu B, Leven A, Stamm S, Einkorn H, Schwalenstocker B et al. (2003). J Neurosci Res 71: 819-825.
24. Nishi H, Nakada T, Kyo S, Inoue M, Shay JW, Isaka K. (2004). Mol Cell Biol 24: 6076-6083.
25. Plumb JA, Bilsland A, Kakani R, Zhao J, Glasspool RM, Knox RJ et al. (2001). Oncogene 20: 7797-7803.
26. Reynolds TY, Rockwell S, Glazer PM. (1996). Cancer Res 56: 5754-5757.
27. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee A, Yoshida H et al. (2004). Cancer Res 64: 5943-5947.
28. Seimiya H, Tanji M, Oh-hara T, Tomida A, Naasani I, Tsuro T. (1999). Biochem Biophys Res Commun 260: 365-370.
29. Shi Y, Sawada J, Sui G, Affar EB, Whetstine JR, Lan F et al. (2003). Nature 422: 735-738.
30. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. (1998). Cancer Res 58: 4168-4172.
31. Yatabe N, Kyo S, Maida Y, Nishi H, Nakamura M, Kanaya T et al. (2004). Oncogene 23: 3708-3715.
32. Zaffaroni N, Porta CD, Villa R, Botti C, Buglioni S, Mottolese M et al. (2002). J Pathol 198: 37-46.
33. Zhang C, Dowd DR, Staal A, Gu C, Lian JB, van Wijnen AJ et al. (2003a). J Biol Chem 278: 35325-35336.
34. Zhang L, Johnson M, Le KH, Sato M, Ilagan R, Iyer M et al. (2003b). Cancer Res 63: 4552-4560.